Clinical trial
Folate Supplementation in Schizophrenia
NCT00249288 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00249288 |
|---|---|
| Title | Folate Supplementation in Schizophrenia |
| Official title | Folate Supplementation in Schizophrenia |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | National Alliance for Research on Schizophrenia and Depression |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Folate, Placebo |
| Enrollment | 46 |
| Start date | Dec 1, 2003 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Nov 7, 2005 |
| Last update posted | Apr 5, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: